Safety, Tolerability, and Immunogenicity of the Invaplex(AR-Detox)Shigella Vaccine Co-Administered with the dmLT Adjuvant in Dutch and Zambian Adults: Study Protocol for a Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase Ia/b Clinical Trial
在荷兰和赞比亚成年人中，Invaplex(AR-Detox)志贺氏菌疫苗与dmLT佐剂联合给药的安全性、耐受性和免疫原性：一项多中心、随机、双盲、安慰剂对照、剂量递增的Ia/b期临床试验的研究方案
期刊:Vaccines
影响因子:3.4
doi:10.3390/vaccines13010048
Roozen, Geert V T; Sukwa, Nsofwa; Chirwa, Masuzyo; White, Jessica A; Estrada, Marcus; Maier, Nicole; Turbyfill, Kevin R; Laird, Renee M; Suvarnapunya, Akamol E; Sayeh, Aicha; D'Alessio, Flavia; Marion, Candice; Pattacini, Laura; Hoogerwerf, Marie-Astrid; Murugan, Rajagopal; Terrinoni, Manuela; Holmgren, Jan R; Sirima, Sodiomon B; Houard, Sophie; Simuyandi, Michelo; Roestenberg, Meta
